Mode
Text Size
Log in / Sign up

NTIS subtypes and thyroid antibodies associated with higher in-hospital mortality in sepsis cohortThyroid Antibodies Signal Higher Death Risk in Sepsis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider NTIS and thyroid antibodies as potential risk markers in sepsis, but recognize this is observational evidence.

A retrospective cohort study analyzed 871 patients with sepsis admitted to a tertiary hospital in Shanghai. The study examined the association between non-thyroidal illness syndrome (NTIS) subtypes, thyroid autoantibodies (TGAb, TPOAb), and in-hospital mortality, comparing patients with and without NTIS.

NTIS was an independent predictor of in-hospital mortality with an odds ratio of 3.14 (95% CI 1.52–7.00, p = 0.003). The NTIS-1 subtype showed an OR of 4.26 (95% CI 1.33–16.41, p = 0.022) and NTIS-2 subtype an OR of 3.99 (95% CI 1.31–14.88, p = 0.024). TGAb positivity was a prognostic factor in the overall cohort (OR 2.15, 95% CI 1.30–3.60, p < 0.01) and in the NTIS subgroup (OR 1.97, 95% CI 1.17–3.33, p = 0.011). TPOAb positivity showed a non-significant trend toward increased mortality (OR 1.74, 95% CI 0.96–3.14, p = 0.068).

Safety and tolerability data were not reported. The study has several limitations: it is a single-center retrospective design, follow-up duration was not reported, and absolute mortality numbers were not provided. The findings represent associations, not causation, and generalizability beyond similar settings is uncertain.

For clinical practice, these results suggest thyroid function tests combined with antibody measurements might potentially enhance risk stratification in sepsis patients. However, given the observational nature and limitations, these findings should be interpreted cautiously and require prospective validation before influencing management decisions.

The Hidden Danger in Your Bloodwork

Imagine a patient fighting for their life in the ICU. Doctors are rushing to treat the infection, but a confusing blood test result sits on the chart. The thyroid numbers look strange, but no one knows exactly what it means for survival.

This study changes that confusion. It reveals that specific patterns in thyroid levels act as a warning sign for death in sepsis.

Sepsis is a life-threatening reaction to an infection. It happens when your body's immune system goes into overdrive. This response can damage your organs and lead to shock.

Many people get sepsis every year. It affects the elderly, those with chronic diseases, and even healthy people after a severe infection.

Doctors currently focus on the infection itself. They give antibiotics and support failing organs. But they often ignore the strange thyroid changes that happen during illness.

These changes are called Non-thyroidal Illness Syndrome, or NTIS. It is very common in sick patients. Yet, doctors have not fully understood which types of NTIS are most dangerous.

The surprising shift

For a long time, doctors thought low thyroid levels were just a side effect of being sick. They believed the body was simply shutting down to save energy.

But here is the twist. This new research shows that the specific pattern of these low levels predicts who will survive. Some patterns are much worse than others.

What scientists didn't expect

The researchers looked at four different patterns of thyroid hormones. They found that two specific types carried a very high risk of death.

Think of your thyroid hormones like a traffic light. Usually, they tell your body how fast to run. In sepsis, the light turns yellow or red.

The study found that when only one hormone drops, or when two drop together, the risk jumps. It is like a car with two flat tires; it cannot move safely.

The strongest warning sign

The most important finding involved antibodies. These are proteins your immune system makes to fight invaders. Sometimes, they mistakenly attack your own thyroid gland.

The study found that a specific antibody called TGAb was a huge red flag. If this antibody was present, the risk of dying doubled.

This was true even after accounting for how sick the patient was. It means the antibody itself adds extra danger.

This doesn't mean this treatment is available yet.

The team studied 871 patients with sepsis in Shanghai. They checked thyroid levels within 24 hours of diagnosis.

Most patients had some form of NTIS. About 82% of them showed these abnormal thyroid patterns.

When they compared patients with NTIS to those without, the difference was clear. Those with NTIS were older and sicker. They had more health problems before getting sepsis.

Their organs were also failing faster, as shown by higher scores on a standard severity test.

After adjusting for these factors, NTIS still predicted death. The risk was more than three times higher.

Two specific subtypes were the worst. Patients with these patterns faced about a fourfold higher risk of dying.

The presence of the TGAb antibody was the strongest predictor. It doubled the risk of death in the whole group.

Another antibody, TPOAb, showed a similar trend. However, the numbers were not quite strong enough to be certain.

This information helps doctors see the big picture sooner. If a patient has sepsis and abnormal thyroid tests, doctors now know to watch them closely.

It does not mean you need thyroid medication right away. The goal is better risk assessment.

If you or a loved one has sepsis, ask about thyroid tests. Knowing the specific pattern can help the medical team plan better care.

It is important to talk to your doctor about these results. They can explain what the numbers mean for your specific situation.

The limitations

This study has some limits. It looked at patients in one hospital in Shanghai. The results might differ in other places.

The study was also retrospective. This means they looked at past records. It is hard to know exactly what happened before the data was recorded.

Also, the study did not test any new treatments. It only looked at who was likely to die.

More research is needed to confirm these findings. Scientists will likely study patients in different countries.

They may also look at whether treating the thyroid helps patients live longer.

Until then, doctors will use these results to identify high-risk patients. Early detection could save lives by allowing for more aggressive support.

Understanding these subtle signals gives hope. It shows that even small changes in the body can guide us to better outcomes.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedMar 2026
View Original Abstract ↓
BackgroundNon-thyroidal illness syndrome (NTIS) is frequently observed in patients with sepsis; however, prognostic differences among its subtypes remain poorly defined. This study aimed to evaluate whether different NTIS subtypes and the presence of thyroid autoantibodies are associated with mortality in septic patients.MethodsWe conducted a retrospective cohort study including 871 patients with sepsis admitted to a tertiary hospital in Shanghai between 2015 and 2019. Thyroid function tests were performed within 24 hours of sepsis diagnosis. NTIS was categorized into four subtypes according to serum free triiodothyronine (FT3), free thyroxine (FT4), and thyroid-stimulating hormone (TSH) levels: NTIS-1 (isolated low T3), NTIS-2 (combined low T3 and T4), NTIS-3 (low T3 with preserved TSH response), and NTIS-4 (near-normal thyroid hormone levels with mild abnormalities). Thyroid antibodies, including thyroglobulin antibody (TGAb) and thyroid peroxidase antibody (TPOAb), as well as other clinical and laboratory parameters, were measured. The primary outcome was in-hospital mortality. Multivariable logistic regression analyses were performed, adjusting for age, sex, comorbidities, Sequential Organ Failure Assessment (SOFA) score, infection site, and relevant laboratory variables.ResultsNTIS was present in 82% of patients (715/871). Compared with patients without NTIS, those with NTIS were older, had a higher burden of comorbidities, and exhibited more severe organ dysfunction, as reflected by higher SOFA scores (all p < 0.01). After multivariable adjustment, NTIS remained an independent predictor of in-hospital mortality, conferring more than a threefold increased risk (odds ratio [OR] 3.14, 95% confidence interval [CI] 1.52–7.00, p = 0.003). Among NTIS subtypes, both NTIS-1 (OR 4.26, 95% CI 1.33–16.41, p = 0.022) and NTIS-2 (OR 3.99, 95% CI 1.31–14.88, p = 0.024) were associated with approximately a fourfold higher risk of death. TGAb positivity emerged as the strongest prognostic factor, doubling the risk of mortality in the overall cohort (OR 2.15, 95% CI 1.30–3.60, p < 0.01) as well as in the NTIS subgroup (OR 1.97, 95% CI 1.17–3.33, p = 0.011). TPOAb positivity showed a similar trend toward increased mortality but did not reach statistical significance (OR 1.74, 95% CI 0.96–3.14, p = 0.068).ConclusionsNTIS is highly prevalent among patients with sepsis and independently predicts in-hospital mortality after adjustment for disease severity. Patients with NTIS-1 and NTIS-2 subtypes are at particularly high risk of death. Moreover, TGAb positivity is a strong and independent predictor of mortality. Incorporating thyroid function tests together with thyroid antibody measurements may enhance risk stratification in patients with sepsis.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.